COUNCIL FOR INTERNATIONAL ORGANIZATIONS OF MEDICAL SCIENCES
The Council for International Organizations of Medical Sciences (CIOMS) is an international, non-governmental, non-profit organization established jointly by WHO and UNESCO in 1949. CIOMS represents a substantial proportion of the biomedical scientific community through its member organizations, which include many of the biomedical disciplines, national academies of sciences and medical research councils. CIOMS mission is to advance public health through guidance on health research and policy including ethics, medical product development and safety. CIOMS is in official relations with WHO and is an associate partner of UNESCO.
MoreCioms news
RECENT PUBLICATIONS
The Council for International Organizations of Medical Sciences (CIOMS) is an international, non-governmental, non-profit organization established jointly by WHO and UNESCO in 1949. CIOMS represents a substantial proportion of the biomedical scientific community through its member organizations, which include many of the biomedical disciplines, national academies of sciences and medical research councils. CIOMS mission is to advance public health through guidance on health research including ethics, medical product development and safety.
Please visit shop
CIOMS WORKING GROUPS
The Council for International Organizations of Medical Sciences (CIOMS) is an international, non-governmental, non-profit organization established jointly by WHO and UNESCO in 1949. CIOMS represents a substantial proportion of the biomedical scientific community through its member organizations, which include many of the biomedical disciplines, national academies of sciences and medical research councils. CIOMS mission is to advance public health through guidance on health research including ethics, medical product development and safety.
The current and recent Working Groups
- Good Governance Practice for Research Institutions
- Recommended Standards of Education and Training for Health Professionals Participating in Medicines Development
- Severe Cutaneous Adverse Reactions to Drugs – SCARs
- Working Group XIII – Real-World Data and Real-World Evidence in Regulatory Decision Making
- Working Group XII – Benefit-Risk Balance for Medicinal Products
- MedDRA Labelling Groupings
- Working Group XI – Patient Involvement
CIOMS MEETINGS
Upcoming Meetings
01 June 2022
Virtual
CIOMS General Assembly
07 June 2022
Virtual
14th meeting of the Working Group XIII on Real-World Data & Evidence in Regulatory Decision-Making
Recent Meetings
Member Organizations
